respiratory

TSANZSRS 19

Friday 29th - Tuesday 2nd April 2019
Lung cancer

Professor Ian Yang: exploring coexisting COPD and lung cancer

The devastating diagnosis of lung cancer in patients with COPD has led to some interesting observations such as the apparent higher sensitivity to immune checkpoint inhibitors (ICIs) in patients with both diseases compared to lung cancer alone. Speaking at TSANZSRS 2019,...

The devastating diagnosis of lung cancer in patients with COPD has led to some interesting observations such as the apparent...
Public Health

The respiratory impacts of mining extend to communities: expert

Coal mining is not only an occupational health issue for miners but also a public health issue for residents, particularly in vulnerable communities. Professor Michael Hendryx, from the University of Indiana and a Fulbright Distinguished Chair at the University of Newcastle,...

Coal mining is not only an occupational health issue for miners but also a public health issue for residents, particularly...
Medicines

Biologics and respiratory complications: no overt PE risk with TK inhibitors

Respiratory physicians asked for their take on the possible pulmonary side effects of small molecule tyrosine kinase inhibitors (TKIs) can reassure their colleagues. According to a meta-analysis of all published trial data on adverse events, there is some signal for infections...

Respiratory physicians asked for their take on the possible pulmonary side effects of small molecule tyrosine kinase inhibitors (TKIs) can...